Gs-6620, a Liver-Targeted Nucleotide Prodrug, Exhibits Antiviral Activity and Favorable Safety Profile Over 5 Days in Treatment Naive Chronic Hcv Genotype 1 Subjects Academic Article
Overview
publication date
- 2012-04-01
Additional Document Info
start page
- S470
end page
- S471
volume
- 56